[Ocular Behçet disease. Retrospective study].
OBJECTIVE
To study clinical features, visual prognosis and response to immunosuppressive drugs in patients with ocular Behçet Disease (BD).


METHODS
clinical data of 17 patients (33 eyes) were retrospectively reviewed from May 1996 to May 2003.


RESULTS
The male/female ratio was 12/5. The commonest manifestations were oral ulceration (100%) and skin lesions (88%). Anterior uveitis was present in 59%, posterior uveitis was in 76% and panuveitis was in 88.1%. Visual acuity improved in 11 (33.3%) eyes, remind stable in 18 (54.5%) eyes and four (12.1%) eyes lost two or more lines. Main drug therapy consisted of colchicine and cyclosporine (59%). Seven patients had received three drugs simultaneously.


CONCLUSIONS
BD can lead to an irreversible visual loss; however, the visual prognosis is good (85%) if immunosuppressor treatment is implemented.
Torres
R M
RM
Unidad de Inmunología Ocular, Instituto Universitario de Oftalmobiología Aplicada, Universidad de Valladolid, Valladolid, Spain.
Yáñez
B
B
Herreras
J M
JM
Calonge
M
M
D000293:Adolescent; D000328:Adult; D001528:Behcet Syndrome / Q000150:complications*; D002648:Child; D002675:Child, Preschool; D005128:Eye Diseases / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies